Equities

Balance Labs Inc

BLNC:PKC

Balance Labs Inc

Actions
  • Price (USD)0.1831
  • Today's Change0.00 / 0.00%
  • Shares traded300.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 16:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Balance Labs Inc had revenues fall -100.00% from 247.50k to 0.00, though the company grew net income from a loss of 768.35k to a smaller loss of 381.57k.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-163.03%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Balance Labs Inc fell by 122.50k. In addition, the company used more cash to support its operations than it earned, posting a cash flow loss of 122.50k. In addition the company used on investing activities and also paid in financing cash flows.
Cash flow per share-0.0192
Price/Cash flow per share--
Book value per share-0.2196
Tangible book value per share-0.2196
More ▼

Balance sheet in USDView more

Balance Labs Inc uses little or no debt in its capital structure.
Current ratio0.0348
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.